Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
1999-10-27
2002-03-26
Brusca, John S. (Department: 1631)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100
Reexamination Certificate
active
06361947
ABSTRACT:
BACKGROUND OF THE INVENTION
The past years have seen a dynamic change in the ability of science to comprehend vast amounts of data. Pioneering technologies such as nucleic acid arrays allow scientists to delve into the world of genetics in far greater detail than ever before. Exploration of genomic DNA has long been a dream of the scientific community. Held within the complex structures of genomic DNA lies the potential to identify, diagnose, or treat diseases like cancer, alzheimers or alcoholism. Answers to the world's food distribution problems may be held within the exploitation of genomic information from plants and animals.
It is estimated that by the Spring of 2000 a reference sequence of the entire human genome will be sequenced allowing for types of genetic analysis that were never before possible. Novel methods of sample preparation and sample analysis are needed to provide for the fast and cost effective exploration of complex samples of nucleic acids, particularly genomic DNA.
SUMMARY OF THE INVENTION
The present invention provides a flexible and scalable method for analyzing complex samples of nucleic acids, such as genomic DNA. These methods are not limited to any particular type of nucleic acid sample: plant, bacterial, animal (including human) total genome DNA, RNA, cDNA and the like may be analyzed using some or all of the methods disclosed in this invention. The word “DNA” may be used below as an example of a nucleic acid. It is understood that this term includes all nucleic acids, such as DNA and RNA, unless a use below requires a specific type of nucleic acid. This invention provides a powerful tool for analysis of complex nucleic acid samples. From experimental design to isolation of desired fragments and hybridization to an appropriate array, the invention provides for faster, more efficient and less expensive methods of complex nucleic acid analysis.
The present invention provides for novel methods of sample preparation and analysis comprising managing or reducing, in a reproducible manner, the complexity of a nucleic acid sample. The present invention eliminates the need for multiplex PCR, a time intensive and expensive step in most large scale analysis protocols, and for many of the embodiments the step of complexity reduction may be performed entirely in a single tube. The invention further provides for analysis of the sample by hybridization to an array which may be specifically designed to interrogate fragments for particular characteristics, such as, for example, the presence or absence of a polymorphism. The invention further provides for novel methods of using a computer system to model enzymatic reactions in order to determine experimental conditions and/or to design arrays. In a preferred embodiment the invention discloses novel methods of genome-wide polymorphism discovery and genotyping.
In one embodiment of the invention, the step of complexity management of the nucleic acid sample comprises enzymatically cutting the nucleic sample into fragments, separating the fragments and selecting a particular fragment pool. Optionally, the selected fragments are then ligated to adaptor sequences containing PCR primer templates.
In a preferred embodiment, the step of complexity management is performed entirely in a single tube.
In one embodiment of complexity management, a type IIs endonuclease is used to digest the nucleic acid sample and the fragments are selectively ligated to adaptor sequences and then amplified.
In another embodiment, the method of complexity management utilizes two restriction enzymes with different cutting sites and frequencies and two different adaptor sequences.
In another embodiment of the invention, the step of complexity management comprises performing the Arbitrarily Primed Polymerase Chain Reaction (AP PCR) upon the sample.
In another embodiment of the invention, the step of complexity management comprises removing repeated sequences by denaturing and reannealing the DNA and then removing double stranded duplexes.
In another embodiment of the invention, the step of complexity management comprises hybridizing the DNA sample to a magnetic bead which is bound to an oligonucleotide probe containing a desired sequence. This embodiment may further comprise exposing the hybridized sample to a single strand DNA nuclease to remove the single stranded DNA, ligating an adaptor sequence containing a Class II S restriction enzyme site to the resulting duplexed DNA and digesting the duplex with the appropriate Class II S restriction enzyme to release the magnetic bead. This embodiment may or may not comprise amplification of the isolated DNA sequence. Furthermore, the adaptor sequence may or may not be used as a template for the PCR primer. In this embodiment, the adaptor sequence may or may not contain a SNP identification sequence or tag.
In another embodiment, the method of complexity management comprises exposing the DNA sample to a mismatch binding protein and digesting the sample with a 3′ to 5′ exonuclease and then a single strand DNA nuclease. This embodiment may or may not include the use of a magnetic bead attached to the mismatch binding protein.
REFERENCES:
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4800159 (1989-01-01), Mullis et al.
patent: 5487985 (1996-01-01), McClelland et al.
patent: 5512439 (1996-04-01), Hornes et al.
patent: 5710000 (1998-01-01), Sapolsky et al.
patent: 5712127 (1998-01-01), Malek et al.
patent: 5763239 (1998-06-01), Short et al.
patent: 5837832 (1998-11-01), Chee et al.
patent: 5851770 (1998-12-01), Babon et al.
patent: 5858656 (1999-01-01), Deugau et al.
patent: 5876929 (1999-03-01), Wigler et al.
patent: 6001574 (1999-12-01), Short et al.
patent: 6004783 (1999-12-01), Ausubel et al.
patent: 6013445 (2000-01-01), Albrecht et al.
patent: 6027877 (2000-02-01), Wagner et al.
patent: 6027945 (2000-02-01), Smith et al.
patent: 6033861 (2000-03-01), Schafer et al.
patent: 6060240 (2000-05-01), Kamb et al.
patent: 6060245 (2000-05-01), Sorge et al.
patent: WO93/22457 (1993-11-01), None
patent: WO99/43853 (1999-09-01), None
Chee et al., “Accessing Genetic Information with High-Density DNA Arrays,” Science, 1996, vol. 274, pp. 610-614.*
“Fingerprinting Methods Based on Arbitrarily Primed PCR” M.R. Micheli and R. Borg Eds (1997) Springer Lab Manual, Springer-Verlag Berlin Heidelberg Pubs. see especially Chapter 7 R. Arribas et al. “Arbitrarily Primed PCR and RAPDS”.
Wagner R. and Radman, M. (1995). Mismatch binding protein-based mutation detection systems. In “Methods: a Companion to Methods in Enzymology” 7, 199-203.
Dong Shoulian
Lipshutz Robert J.
Lockhart David J.
Affymetrix Inc.
Affymetrix, Inc.
Brusca John S.
Kim Young
Zhou Wei
LandOfFree
Complexity management and analysis of genomic DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Complexity management and analysis of genomic DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complexity management and analysis of genomic DNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2845079